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ABSTRACT
In this paper we present a framework for validating and
testing an agent-based model that includes determining
the appropriate number of runs to account for variation
in model runs, validating the model and showing that
the model can be used to learn about the system. To
demonstrate the framework we use a case study of an
agent-based model for the spread of infectious diseases.
INTRODUCTION
Agent-based models are a type of simulation that are
made up of agents that can interact with other agents
and with their environment. The actions of these agents
are determined by a set of probabilistic rules. Agentbased models are typically stochastic due to the agent’s
abilities to make decisions and react to their environment and the state of the model. Because of this
stochasticity, each model run can produce different results. Additional variation in model results is often
caused by different initial conditions for each model run.
Thus agent-based model results are a distribution of possible outcomes of the system being modeled. This distribution of results can lead to challenges in presenting the
model results and proving their validity and usefulness.
Agent-based models can have a number of different purposes including prediction, description, and theoretical
exploration (Edmonds et al. 2019) and the different purposes might necessitate changes in how validation and
testing a model is done. It is also necessary to tailor the
methods used for validation so that they fits with the
requirements for the results of the model. For example looking at an average of a single statistic calculated
over the model runs versus looking at changes in agent
behaviour or looking at a distribution of statistics.
Here we present a framework for validating and testing
an agent-based model that is not limited to a specific
model purpose but is instead designed for a model where
the results are presented with a single statistic such as
an average, a percent of runs where an event occurs
or a threshold has been reached, or a single statistic

measuring the change in a model output. We start the
paper by discussing the existing literature on validating
and testing agent-based models and then present our
framework and illustrate each step of the framework via
an accompanying case study of validating and testing
agent-based models for infectious diseases.
BACKGROUND
A major advantage of using agent-based models is that
the approach allows for flexibility in terms of the simulation design. However, once a model is created it does
not mean that the model is valid and producing accurate results. There is no broadly accepted method to
validate agent-based model. This poses a major challenge to the field of agent-based modelling because if a
model is not properly validated, any results, especially
surprising results, that come from the model cannot be
trusted (Richiardi et al. 2006).
The stochasticity in an agent-based model leads to a
distribution of results across model runs; consequently,
a prerequisite to model validation and testing is to decide on the representation of the distribution. Often an
aggregate statistic calculated across model runs is used,
for example an average across the runs or a percentage
of runs where a certain threshold has been reached.
In a review of agent-based models that calculated the
statistical power of the models (the power of a statistical
test is the probability that it correctly rejects a false
null hypothesis), Secchi and Seri (2017) find that the
majority of papers do not perform any estimations of the
robustness of the proposed model and most studies did
not have enough runs to account for the stochasticity in
the model. This could have an impact on the validity of
theses agent-based models. In developing our framework
we have included a process for selecting the number of
models runs necessary to calculate a statistic.
The ideal scenario for validating a model, is comparing the model results to real data, but data is not always available. Thus other methods of validation need
to be used. Within the literature we have found two
other validation methods that are commonly used: (i)
cross-validation or comparing the results of the model
to a previously validated model (Rakowski et al. 2010a,
Skvortsov et al. 2007); and, (ii) showing that appropriate decisions were made in creating the model and that

small change in inputs do not disproportionately affect
the model (Apolloni et al. 2009, Xia et al. 2013). As a
result our model validation process covers all three of
these approaches; cross-validation, a sensitivity analysis, and comparing the model results to real data.
The final stage in our framework is model testing. In
this paper we make a distinction between model validation and model testing. Validation shows that the
model results are trustworthy and that the model is accurately simulating a system whereas testing shows that
the model can test a hypothesis or can add to the existing knowledge about the system being modelled. Both
are important in determining the usefulness of a model.
The following sections describe each step in the framework in greater detail and discuss the application of each
step using a case study of an agent-based model for the
spread of measles in a town. For each model run, a different outbreak scenario (in terms of the population and
the initial infection vector being stochastically sampled)
is created, and to aggregate the data the main statistic that we look at is the percent of runs that result
in a measles outbreak occurring in the town. Note that
model creation, validation, and testing is a detailed process that requires a large amount of work and thus this
case study draws on research from a number of previous
papers: Hunter et al. (2018) and Hunter et al. (2020)
discuss validation, and Hunter and Kelleher (2020) discusses testing. However, this case study extends beyond
this prior work in terms of explaining the process used
to determine the appropriate number of runs necessary
for the model, and also situates the work in these papers
within the overarching validation and testing framework
proposed in this paper.
Stochasticity and Confidence Intervals: Selection of Number of Runs
We propose using the statistical concept of a confidence
interval as the basis for determining the number of runs
necessary to ensure the calculated statistic is representative of the distribution of outcomes the model is sampling from. Confidence intervals relate the uncertainty
about the true value of a statistic (i.e., variability across
a number of samples the statistic is calculated over) with
the sample size used in the calculation of the value. The
relationship between these elements is that in general as
sample size increases the uncertainty relating to a statistical value decreases and this is reflected in the confidence interval around the statistical value becoming
narrower. Confidence intervals provide an ideal basis for
determining the number of runs necessary for an agentbased model: in this context, the sample size is number
of times the model has been run and so confidence intervals relate the uncertainty relating to the value of a
statistic calculated over the model runs with the number
of model runs.
For a given model, our goal in using confidence intervals

is to find out how many runs of the model is typically
required in order for us to have a high confidence that
the statistic calculated over those runs is representative
of the true parameter of the distribution the model is
sampling from. The assumption we make in doing this
analysis is that if we determine the necessary number
of runs of a model for one model scenario (e.g., for one
population of agents, environmental, or intervention scenario) then we can use the same number of runs of the
model to calculate the statistic in a different (but similar) scenario.
To do this we run the model on a scenario a pre-set
number of times: more than what would be expected
to account for the variability. Once the model is run
a given number of times, we take samples of increasing
sizes, the first sample contains the first 5 runs, the second sample contains the first 10 runs, the third sample
contains the first 15 runs, until the final sample contains all runs. For each sample we look at one main
output statistic and the size of the 95% confidence interval around that statistic. By definition a confidence
interval is determined by both the sample size and the
variability in the sample: as the number of runs in the
sample increases the size of the confidence interval will
decrease. The formula for a confidence interval varies
based on the parameter being estimated: mean, proportion, difference in mean or difference in proportion,
and the appropriate formula should be selected for the
model. In the Case Study section we give the formula
for the confidence interval for a single proportion and
demonstrate how it can be used to determine the appropriate number of runs for a model.
The desired size of the confidence interval will vary
based on what is being measured but it should be sufficiently small enough to provide enough confidence that
the aggregated statistic is close to the true population
parameter and that our results would not change significantly if the model was run additional times. An
important benefit of using confidence intervals in this
way is that they naturally account for the complexity of
the distribution of the model, or in other words the calculation of number of runs is dependent on the variation
of outcomes across the runs: the larger the variation in
model outcomes the more runs are required to meet the
confidence interval criterion.
We see determining the number of runs as an important
step in showing that the results of the initial model account for the stochasticity in the model. Additionally,
once the calculation for the number of runs for a given
model has been determined it is not necessary to do the
calculation again for each different scenario the model is
run on. For example, if a base model is created and the
model is run 500 times to determine that 200 runs are
needed to account for stochasticity, then when interventions are added to the model or the model is ported to
an new society, each additional scenario will only need
to be run 200 times.

Case Study: The design goal of our town agent-based
model was to simulate the spread of measles in a number of different Irish towns. In order to find the number
of runs necessary to find a stable result for the model
three towns with varying characteristics were initially
modelled. The three initial towns were Schull (population 987, Area 17.03km2 ), Tramore (population 9,548,
Area 16.60km2 ) and Kenmare (population 2,912, Area
55.61km2 ). For each town we ran the model 1,000 times
keeping all factors besides those related to the town population, such as age specific vaccination rates, area or
town layout, constant.
In this case study, the target statistic we were examining
with the model was the percent of runs that led to a
measles outbreak occurring in the town. To define the
outbreak condition for a run we used the World Health
Organization’s definition of a measles outbreak of two
or more linked cases of measles. As the outbreaks in the
model are affected by the actions of the infected agents
not all runs lead to an outbreak and the percent of runs
that did lead to an outbreak was found to vary between
towns in the model.
In order to find the appropriate number of runs for this
model we divided the runs for each town into different
samples, the first sample containing the first 5 runs, the
second sample containing the first 10 runs, and so on
until all the runs are included in at least one sample.
Then for each sample we calculated the target statistic
and the 95% confidence interval for the statistic given
the sample. As the statistic was a percent or proportion, the formula used is that for the confidence interval
around a single proportion. The equation is presented in
Equation (1) where p̂ is the proportion, n is the sample
size and z is the z statistic for the appropriate confidence
level. For our agent-based model, p̂ is the proportion of
runs that lead to an outbreak, n is the number of runs
and z is 1.96 which creates a 95% confidence interval.
r
p̂(1 − p̂)
(1)
p̂ ± z ∗
n
Table 1 shows selected values of the statistics and confidence intervals for different sample sizes from the 1,000
model runs. From Table 1 it can be seen that the size
of the confidence interval decreases as the size of the
sample increases.
Looking at the size of the confidence intervals, the length
of the 95% confidence interval for all three towns is approximately 10% when the sample size is 300 runs.
The confidence interval for 300 runs of Kenmare has a
length of 9.5%; the confidence interval for 300 runs of
Schull has a length of 10.8% and the confidence interval for Tramore has a length of 10.2%. Therefore, we
determined the 300 runs was an appropriate number of
runs for this town model when calculating this statistic. Using 1,000 runs instead of 300 we cut the length
of the confidence interval down to 5%, however, we decided that decreasing the size of the confidence intervals

Table 1: Percent of Runs Leading to an Outbreak and
Confidence Intervals
Town
Kenmare

Sample Size
5
300
1000

Percent
80.0
77.6
77.4

Confidence Interval
(44.9 115.1)
(72.9 82.4)
(74.8 80.0)

Schull

5
300
1000

100.0
65.0
66.6

(100.0 100.0)
(59.6 70.4)
(63.7 69.5)

Tramore

5
300
1000

40.0
72.0
70.0

(-2.9 82.9)
(66.9 77.1)
(67.2 72.8)

by 5% with an extra 700 runs was not worth the time
and computing power required.
While a 95% confidence interval is a standard selection
for confidence intervals and can be used for any model,
the confidence interval length of 10% is model specific.
It is selected here due to the use of percents as a statistic
and the magnitudes of the percents, however, for other
models or different statistics a smaller or larger confidence interval might be better suited. The advantage of
using confidence intervals in this way is that they can
be applied to any agent-based model to determine the
appropriate number of runs for that particular model.
That is why we believe that this method is a useful approach to make informed decisions on the number of
runs to use for an agent-based model in a given domain.
Model Validation
The next step in our framework is the validation step.
Once we are sure that our results are statistically robust,
its necessary check that the model is producing the expected results and capturing the desired dynamics.
There are three parts to our validation framework: cross
validation, sensitivity analysis and finally comparing to
real data. While we think that all three are important in
validating a model, in some scenarios all three might not
be necessary or possible. For example, real data to compare the model results to might not be available. The
following sections describe each part of the validation
framework in more detail.
Cross Validation
We first consider cross validation: using the results of
another previously validated model as a baseline for
the agent-based model results. Here the outputs of
the agent-based model are compared against the outputs of the previously validated model. If this comparison shows that the outputs of the two models are
similar then this cross-validation provides evidence that
the agent-based model is producing the overall general
dynamics that would be expected in the type of system
being modelled. This is important to show especially

in the case of a model simulating something such as an
infectious disease outbreak where the dynamics are well
known. If the new model does not produce the expected
dynamics then the model should not be validated. If
the model does produce the expected dynamics then the
modeler can move on to the next step in the validation
framework.
Case Study: In infectious disease modelling the most
commonly accepted and used model type are SEIR (susceptible, exposed, infected, recovered) models which
have been shown to capture the macro level dynamics of
an outbreak. Consequently, for our work an SEIR model
was a natural choice to cross-validate the agent-based
model. If a simple version of the agent-based model was
able to emulate the general dynamics of an SEIR model
of the same domain it could be concluded that the basic
dynamics of the model are working correctly and that
complexity can be added to the model. In the town
model, to compare the agent-based model to the SEIR
model both models were run with an entirely susceptible population. Figure 1 shows the results for the SEIR
model and 10 runs of the agent-based model. Although
they do not produce exactly the same results, the figure
shows that the two models follow the same dynamics:
for example, in both cases the peak of the exposed is
before the peak of the infected and the exposed peak
is higher. Our agent-based model of infectious diseases
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Figure 1: Cross Validation Comparing a SEIR Model
to an Agent-Based Model (Black Plots are the SEIR
Model)
was used to analyse disease dynamics at two geographic
scales: at the individual town level, and at region level.
Although the town level version of our model was crossvalidated against an SEIR model, to cross-validate the
region level model we used the town agent-based model.
To do this, outbreaks in the individual isolated towns
were compared to the outbreaks in the towns where
commuting to other towns was allowed but no agents
who lived outside the town were included and also to
simulated outbreaks in the town when the towns were
connected in a larger network of towns that make up
a region. Table 2 shows results previously presented in
Hunter et al. (2020) that were used to cross validate the

county model with the town model. While the results
for the isolated town and the town within a county were
not identical, the results for the county model are between the isolated and commuting town model results
which we interpret as showing that the outbreaks within
a town were somewhat stable when the town becomes
part of a network but that commuting and interacting
with other agents outside of the town had an effect on
the results.
Table 2: Cross Validation from Hunter et al. (2020)
Model
Town Model
Town Commuting
County Model

Manorhamilton
66.3 (61.0, 71.7)
41.0 (35.4, 46.6)
52.7 (47.0, 58.3)

Kinlough
48.0 (42.3, 53.7)
32.0 (26.7, 27.3)
42.5 (36.1, 47.2)

The fact that the town agent-based model is crossvalidated with an SEIR model, and that the region
agent-based model is cross-validated with the town
agent-based model, demonstrates the potential flexibility of the cross-validation approach in terms of defining
the baseline model that validation is carried out against.
Sensitivity Analysis
After cross validation is completed it may be necessary
to consider a sensitivity analysis. Although sensitivity
analysis is often done to analyze how stochasticity affects the variability of results (Raimbault et al. 2019),
here we use a sensitivity analysis as a method to determine if the response of the model to changes in its
parameters is appropriate. To do this it is important to
determine what parameters should be investigated and
what range of those parameters should be used in the
analysis. Determining which parameters to vary and
what range of values to use during sensitivity analysis
is done on the basis of domain theory. For example, in
the field of infectious diseases we would expect that as
the vaccination rate for a disease in a population drops
the number of infected people in a simulation of an outbreak within that population should generally increase.
As we will discuss below in the case study, this type of
domain information provides a basis for designing sensitivity analysis tests for a model. If as the values of
the parameters are changed something unexpected occurs in the model results, the results should be investigated to determine why the model is not behaving as the
system being modeled is expected to. In doing a sensitivity analysis it is important to test the extremes that
might not be likely to occur but where the model might
break down. While in most cases a sensitivity analysis is
important in validating the model, the requirement for
sensitivity analysis of a model does not always hold, for
example if a model is being scaled up from a previously
validated model and no new parameters are added.

Case Study: The parameter selected to show in the
case study for sensitivity analysis is the vaccination rates
of the agents. The parameter was selected as it is a parameters that there are strong expectation with regards
to how the model results should change as the parameter changed. Table 3 shows results for three vaccination
scenarios which shows that the average number of infected agents across model runs and the number of runs
leading to an outbreak decrease as the immunity level in
the population increases. As the expected patterns were
observed when changing vaccination rates this helps to
show that the model is valid.
Table 3: Sensitivity Analysis from Hunter et al. (2018)
Immunity Level
No Immunity
All Immune
Herd Immunity

Average Infected
726.7
1.0
3.3

Percent Outbreaks
94
0
52

Comparison to Data
The last step in validation process is comparing the results of the model to real data. When comparing the
results of the model to data it is essential to understand
that when run multiple times each run of an agent-based
model simulates a different possible scenario and the majority of runs will not predict the exact data. For the
case of an infectious disease model, the type of data typically used for this comparison are previous outbreaks of
a disease in a population. The course of an infectious
disease outbreak depends on a number of factors, including who the initially infected individual was and the
decisions of that individual about staying home when
sick or going out to potentially infect others, and the
attributes of the other agents the infected agent comes
into contact with such as their vaccination status. Thus
when comparing to real data, we want to make sure that
the distribution of outcomes generated by the model is
such that the real data could be considered a likely sample from the distribution.
Case Study: The actual steps in the comparison to
real data will be determined by the domain of the model
and the data available but here we compared the results
from a simulated measles outbreak in the town of Schull
in Ireland, to a real outbreak in Schull in 2012. While
in the other analyses for the town model the percent
of runs that lead to an outbreak was the main statistic
that was studied, when comparing to a real outbreak
we needed to consider other ways to compare our model
results to the real outbreak data.
One measure to look at was the total number infected
in the outbreak which was compared to the number of
infected agents in the model. As the agent-based model
produces a distribution of runs each driven by a different outbreak scenario, we did not expect to have every

model run produce the exact number of infected in the
real outbreak. Instead we expected the real number to
be in the range of model results, to determine if this was
the case for the town model, we checked if the real data
was within the interquartile range of the model result.
As it was, we showed that the real outbreak is one of
the possible scenarios simulated in the model.
Model Testing
The final step in the model validation and testing process is testing the model. A model is only useful if it can
help us learn something that we did not already know
about the system. Thus it is important as a final step
of the modelling process to determine if the model is
able to do that. Similar to the comparison to data the
model testing can be domain specific but should show
some aspect of how a model can be ported to different scenarios, for example different populations, or how
changing different inputs to the model or agent actions
might influence the system.
Case Study: The county model was tested by looking
at the role of the centrality of a town in the spread of
an outbreak (Hunter et al. 2020) and also through using the knowledge gained from the centrality analysis to
implement a school closure intervention. School closure
strategies are often questioned in their effectiveness in
mitigating an outbreak especially with their high social
and economic cost. The county model tests a school
closure strategy that used the knowledge of a town’s
place in a network of towns to decide which schools to
close based on distance to the town where the outbreak
starts and the centrality of the towns in the county’s
commuting network. The study showed that closing the
schools in the town where the outbreak starts and the
highest centrality town in the commuting network had
a mitigating effect on the outbreak (Hunter and Kelleher 2020). This allowed us to conclude that not only is
the model working as we expect it should but that it is
a useful model that can help us to learn about the system being modelled which can aid in planning for future
outbreaks.
CONCLUSION
A framework for model validation and testing is important when creating a model to show that the results can
be used for accurate predictions. If agent-based models
are to be routinely used as policy tools a consistent validation method should be determined. Without such a
method it may be difficult to distinguish a model that
will provide accurate results for a given population from
a model that will not. However, there is no set framework in the literature. In this paper we presented a
framework that can be applied to agent-based models,

and used an agent-based model for the spread of infectious diseases as a case study. While the framework was
developed in validating the model for infectious disease
spread it contains methods that will be useful to models in other domains. The framework is multi-step and
involves determining the number of runs that are necessary to make sure that the model results are representative, validating the model through cross-validation, sensitivity analysis and comparing the model to real data if
possible, and finally testing that the model can provide
useful results.
What we have proposed is a validation and testing
framework that can be adjusted to better suit a given
model. The framework was created for an agent-based
model for the spread of infectious diseases the primary
purpose of which was explanation or description, and
the framework is most applicable to other models designed for similar purposes. We believe, however, that
our framework is a useful starting point for an agentbased modeller to help determine the appropriate process for model validation even if the model does not fit
into the same categories as the models used as an example here. Determining the number of runs that should
be done taking into account the variability in the model
is essential in providing results that can be trusted and
the method using the size of the confidence interval and
the stability of the model results presented here can be
used for many other types of agent-based models. While
it might not be possible to present a multi-step validation process for every model, as we do here, using at
least one of the steps should help provide some proof
of model validation. Finally, a model should only be
created if we can learn something from it to increase
our knowledge of the system which is why the final step
in our framework is testing the model. For instance, if
the model is designed to predict a phenomenon first it
should be shown that the predictions are valid and then
the final step should show that we are able to learn more
about the system using the model.
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P.; Root H.; and Squazzoni F., 2019. Different
Modelling Purposes. Journal of Artificial Societies
and Social Simulation, 22, no. 3, 6. ISSN 14607425. 10.18564/jasss.3993. URL http://jasss.soc
.surrey.ac.uk/22/3/6.html.
Hunter E. and Kelleher J., 2020. Using a Hybrid Agent-

Based and Equation Based Model to Test School Closure Policies. 10.21203/rs.3.rs-20889/v1. Preprint.
Hunter E.; Mac Namee B.; and Kelleher J., 2018. An
open-data-driven agent-based model to simulate infectious disease outbreaks. PLOS ONE, 13, no. 12, 1–
35. 10.1371/journal.pone.0208775. URL https://
doi.org/10.1371/journal.pone.0208775.
Hunter E.; Mac Namee B.; and Kelleher J.D., 2020.
A Model for the Spread of Infectious Diseases in a
Region. International Journal of Environmental Research and Public Health, 17, no. 9, 3119. URL
https://doi.org/10.3390/ijerph17093119.
Raimbault J.; Cottineau C.; Le Texier M.; Le Nechet
F.; and Reuillon R., 2019. Space Matters: Extending Sensitivity Analysis to Initial Spatial Conditions
in Geosimulation Models. Journal of Artificial Societies and Social Simulation, 22, no. 4, 10. ISSN 14607425. 10.18564/jasss.4136. URL http://jasss.soc
.surrey.ac.uk/22/4/10.html.
Rakowski F.; Gruziel M.; Bieniasz−Krzywiec L.;
and Radomski J.P., 2010a.
Influenza epidemic spread simulation for Poland — a large
scale, individual based model study. Physica A:
Statistical Mechanics and its Applications, 389,
no. 16, 3149 – 3165.
10.1016/j.physa.2010
.04.029.
URL http://www.sciencedirect.com/
science/article/pii/S0378437110003687.
Richiardi M.; Leombruni R.; Saam N.J.; and Sonnessa
M., 2006. A Common Protocol for Agent-Based Social Simulation. Journal of Artificial Societies and
Social Simulation, 9, no. 1, 15. ISSN 1460-7425. URL
http://jasss.soc.surrey.ac.uk/9/1/15.html.
Secchi D. and Seri R., 2017. Controlling for ‘false
negatives’ in agent-based models. A review of power
analysis in organizational research. Computational
and Mathematical Organization Theory, 23, 94–121.
10.1007/s10588-016-9218-0.
Skvortsov A.T.; Connell R.B.; Dawson P.D.; and Gailis
R.M., 2007. Epidemic Modelling: Validation of
Agent-based Simulation by Using Simple Mathematical Models. International Congress on Simulation
and Modelling, 657–662. URL http://mssanz.org
.au.previewdns.com/MODSIM07/papers/13 s20/
EpidemicModeling s20 Skvortsov .pdf.
Xia H.; Barrett C.; Chen J.; and Marathe M.V., 2013.
Computational Methods for Testing Adequacy and
Quality of Massive Synthetic Proximity Social Networks. CSE ’13 Proceedings of the 2013 IEEE 16th International Conference on Computational Science and
Engineering, 1113–1120. URL http://staff.vbi.vt
.edu/chenj/pub/NDSSL-TR-13-153.pdf.

